These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7870671)

  • 1. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing.
    de Villiers MM; Van der Watt JG
    Pharm Res; 1994 Nov; 11(11):1557-61. PubMed ID: 7870671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug agglomeration and dissolution--what is the influence of powder mixing?
    Kale K; Hapgood K; Stewart P
    Eur J Pharm Biopharm; 2009 May; 72(1):156-64. PubMed ID: 19347972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polydisperse powder mixtures: effect of particle size and shape on mixture stability.
    Swaminathan V; Kildsig DO
    Drug Dev Ind Pharm; 2002 Jan; 28(1):41-8. PubMed ID: 11858523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the de-agglomeration and dissolution of a poorly water soluble drug by decreasing the agglomerate strength of the cohesive powder.
    Allahham A; Stewart PJ; Das SC
    Int J Pharm; 2013 Nov; 457(1):101-9. PubMed ID: 24080334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the deagglomeration of micronized benzodiazepines from powder mixtures added to dissolution media.
    Zhao FY; Stewart PJ
    J Pharm Sci; 2004 Jun; 93(6):1618-27. PubMed ID: 15124218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic time scales in adhesive mixing investigated by dry particle sizing.
    Nguyen D; Rasmuson A; Niklasson Björn I; Thalberg K
    Eur J Pharm Sci; 2015 Mar; 69():19-25. PubMed ID: 25576090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding improved dissolution of indomethacin through the use of cohesive poorly water-soluble aluminium hydroxide: effects of concentration and particle size distribution.
    Tay T; Allahham A; Morton DA; Stewart PJ
    J Pharm Sci; 2011 Oct; 100(10):4269-80. PubMed ID: 21560127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic energy density and agglomerate abrasion rate during blending of agglomerates into powders.
    Willemsz TA; Hooijmaijers R; Rubingh CM; Tran TN; Frijlink HW; Vromans H; van der Voort Maarschalk K
    Eur J Pharm Sci; 2012 Jan; 45(1-2):211-5. PubMed ID: 22127372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a change in crystal polymorph on the degree of adhesion between micronized drug particles and large homogenous carrier particles during an interactive mixing process.
    Song M; de Villiers MM
    Pharm Dev Technol; 2004 Nov; 9(4):387-98. PubMed ID: 15581075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Content uniformity of microdose tablets (dosage 1 microgram--10 mg) produced by fluid bed granulation of interactive mixtures.
    Thiel WJ; Nguyen LT; Sberna FJ
    J Pharm Pharmacol; 1986 May; 38(5):335-43. PubMed ID: 2872308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
    Shalash AO; Elsayed MMA
    AAPS PharmSciTech; 2017 Nov; 18(8):2862-2870. PubMed ID: 28421352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interactions between powder particle size and binder viscosity on agglomerate growth mechanisms in a high shear mixer.
    Johansen A; Schaefer T
    Eur J Pharm Sci; 2001 Jan; 12(3):297-309. PubMed ID: 11113649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-excipient interactions resulting from powder mixing. III: Solid state properties and their effect on drug dissolution.
    Chowhan ZT; Chi LH
    J Pharm Sci; 1986 Jun; 75(6):534-41. PubMed ID: 3735096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De-agglomeration of micronized benzodiazepines in dissolution media measured by laser diffraction particle sizing.
    Zhao FY; Stewart PJ
    J Pharm Pharmacol; 2003 Jun; 55(6):749-55. PubMed ID: 12841934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of ordered mixtures for improving the dissolution rate of low solubility compounds.
    Nyström C; Westerberg M
    J Pharm Pharmacol; 1986 Mar; 38(3):161-5. PubMed ID: 2871148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deaggregation during the dissolution of benzodiazepines in interactive mixtures.
    Liu J; Stewart PJ
    J Pharm Sci; 1998 Dec; 87(12):1632-8. PubMed ID: 10189279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose.
    Allahham A; Stewart PJ
    Eur J Pharm Biopharm; 2007 Nov; 67(3):732-42. PubMed ID: 17540551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.